254 related articles for article (PubMed ID: 18055997)
1. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels.
Lijfering WM; Veeger NJ; Brouwer JL; van der Meer J
Haematologica; 2007 Dec; 92(12):1703-6. PubMed ID: 18055997
[TBL] [Abstract][Full Text] [Related]
2. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.
Lijfering WM; Coppens M; van de Poel MH; Middeldorp S; Hamulyák K; Bank I; Veeger NJ; Prins MH; Büller HR; van der Meer J
Thromb Haemost; 2007 Aug; 98(2):457-63. PubMed ID: 17721631
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels.
Lijfering WM; Coppens M; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Büller HR; van der Meer J
Thromb Res; 2008; 123(2):244-50. PubMed ID: 18279917
[No Abstract] [Full Text] [Related]
4. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
[TBL] [Abstract][Full Text] [Related]
6. [A new thrombophilia risk factor: the increase of plasma factor VIII].
Hernández-Jerónimo J; Pérez-Campos E; Matadamas C; Majluf-Cruz A
Rev Invest Clin; 2003; 55(4):448-57. PubMed ID: 14635611
[TBL] [Abstract][Full Text] [Related]
7. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S
Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609
[TBL] [Abstract][Full Text] [Related]
8. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism.
O'Donnell J; Laffan M
Clin Lab; 2001; 47(1-2):1-6. PubMed ID: 11214218
[TBL] [Abstract][Full Text] [Related]
10. Venous thrombosis, oral contraceptives and high factor VIII levels.
Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
Kamphuisen PW; Eikenboom JC; Vos HL; Pablo R; Sturk A; Bertina RM; Rosendaal FR
Thromb Haemost; 1999 May; 81(5):680-3. PubMed ID: 10365736
[TBL] [Abstract][Full Text] [Related]
12. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
Nossent AY; Eikenboom JC; Vos HL; Bakker E; Tanis BC; Doggen CJ; Bertina RM; Rosendaal FR
Thromb Haemost; 2006 Jun; 95(6):942-8. PubMed ID: 16732372
[TBL] [Abstract][Full Text] [Related]
13. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.
Mello TB; Siqueira LH; Montavão SA; Ozello MC; Annichino-Bizzacchi JM
Thromb Res; 2008; 121(5):625-9. PubMed ID: 17889283
[TBL] [Abstract][Full Text] [Related]
14. [Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group].
Faude F; Faude S; Siegemund A; Wiedemann P
Klin Monbl Augenheilkd; 2004 Oct; 221(10):862-6. PubMed ID: 15499522
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
17. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study.
Kreuz W; Stoll M; Junker R; Heinecke A; Schobess R; Kurnik K; Kelsch R; Nowak-Göttl U
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1901-6. PubMed ID: 16709943
[TBL] [Abstract][Full Text] [Related]
18. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
Keijzer MB; Borm GF; Blom HJ; Bos GM; Rosendaal FR; den Heijer M
Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768
[TBL] [Abstract][Full Text] [Related]
19. The role of cysteine and homocysteine in venous and arterial thrombotic disease.
Marcucci R; Brunelli T; Giusti B; Fedi S; Pepe G; Poli D; Prisco D; Abbate R; Gensini GF
Am J Clin Pathol; 2001 Jul; 116(1):56-60. PubMed ID: 11447752
[TBL] [Abstract][Full Text] [Related]
20. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
